Treatment of multicentric reticulohistiocytosis with adalimumab, minocycline, methotrexate

Int J Rheum Dis. 2013 Feb;16(1):105-6. doi: 10.1111/j.1756-185X.2012.01762.x. Epub 2012 Jun 7.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab
  • Anti-Bacterial Agents / therapeutic use*
  • Anti-Inflammatory Agents / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Drug Therapy, Combination
  • Histiocytosis, Non-Langerhans-Cell / complications
  • Histiocytosis, Non-Langerhans-Cell / diagnosis
  • Histiocytosis, Non-Langerhans-Cell / drug therapy*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Methotrexate / therapeutic use*
  • Middle Aged
  • Minocycline / therapeutic use*
  • Remission Induction
  • Skin Diseases / diagnosis
  • Skin Diseases / drug therapy
  • Skin Diseases / etiology

Substances

  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal, Humanized
  • Immunosuppressive Agents
  • Adalimumab
  • Minocycline
  • Methotrexate